Re: Trial results
in response to
by
posted on
Jun 26, 2013 09:30AM
Edit this title from the Fast Facts Section
Wdnering - This is exactly what I was trying to say (you said it better). MNKD will get early reads on how large homogenous populations performed, but the devil is in the details. What if afrezza works great for the general population but not so well for participants that fit a subset population?